Decreased striatal dopamine transporters in codeine-containing cough syrup abusers

Drug and Alcohol Dependence

Volumn 118, Issue 2-3, 2011, Pages 148-151

  Hou, Haifeng ^a   Yin, Shugui ^b   Jia, Shaowei ^a,c   Hu, Shu ^a   Sun, Taotao ^a   Chen, Qing ^a   Fan, Rong ^a  

^a PEKING UNIVERSITY SHENZHEN HOSPITAL   (China)

^b Shenzhen Civil Life Science and Technology Co Ltd   (China)

^c PEKING UNIVERSITY   (China)

Author keywords

Abuse; Codeine containing cough syrups; Cough medicine; Dependence; Dopamine transporter (DAT); SPECT

Indexed keywords

[2 [[2 [[[3 (4 CHLOROPHENYL) 8 METHYL 8 AZABICYCLO[3.2.1]OCT 2 YL]METHYL](2 MERCAPTOETHYL)AMINO]ETHYL]AMINO]ETHANETHIOLATO]OXOTECHNETIUM TC 99M; ANTITUSSIVE AGENT; CODEINE; DOPAMINE TRANSPORTER;

ADOLESCENT; ADULT; ARTICLE; BRAIN FUNCTION; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; DRUG ABUSE; DRUG DEPENDENCE; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; MALE; NEUROIMAGING; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADOLESCENT; ANTITUSSIVE AGENTS; BRAIN MAPPING; CODEINE; CORPUS STRIATUM; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; MALE; NEUROIMAGING; OPIOID-RELATED DISORDERS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; YOUNG ADULT;

EID: 80053568734     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2011.03.011     Document Type: Article

References (37)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2000, American Psychiatric Press, Washington, DC. 4th ed.
2. Cass W.A., Manning M.W. Recovery of presynaptic dopaminergic functioning in rats treated with neurotoxic doses of methamphetamine. J. Neurosci. 1999, 19:7653-7660.
3. Chang L.T. A method for attenuation correction in radionuclide computed tomography. IEEE Trans. Nucl. Sci. 1978, 25:638-643.
4. Crits-Christoph P., Newberg A., Wintering N., Ploessl K., Gibbons M.B., Ring-Kurtz S., Gallop R., Present J. Dopamine transporter levels in cocaine dependent subjects. Drug Alcohol Depend. 2008, 98:70-76.
5. Danos P., Kasper S., Grunwald F., Klemm E., Krappel C., Broich K., Hoflich G., Overbeck B., Biersack H.J., Moller H.J. Pathological regional cerebral blood flow in opiate-dependent patients during withdrawal: a HMPAO-SPECT study. Neuropsychobiology 1998, 37:194-199.
6. Darboe M.N. Abuse of dextromethorphan-based cough syrup as a substitute for licit and illicit drugs: a theoretical framework. Adolescence 1996, 31:239-245.
7. Dohi T., Kitayama S., Kumagai K., Hashimoto W., Morita K. Pharmacology of monoamine neurotransmitter transporters. Nippon Yakurigaku Zasshi 2002, 120:315-326.
8. Dreher J.C., Kohn P., Kolachana B., Weinberger D.R., Berman K.F. Variation in dopamine genes influences responsivity of the human reward system. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:617-622.
9. Drevets W.C., Gautier C., Price J.C., Kupfer D.J., Kinahan P.E., Grace A.A., Price J.L., Mathis C.A. Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Biol. Psychiatry 2001, 49:81-96.
10. Fischer B., Rehm J., Patra J., Cruz M.F. Changes in illicit opioid use across Canada. CMAJ 2006, 175:1385-1387.
11. Friedman S.D., Castaneda E., Hodge G.K. Long-term monoamine depletion, differential recovery, and subtle behavioral impairment following methamphetamine-induced neurotoxicity. Pharmacol. Biochem. Behav. 1998, 61:35-44.
12. Gerra G., Calbiani B., Zaimovic A., Sartori R., Ugolotti G., Ippolito L., Delsignore R., Rustichelli P., Fontanesi B. Regional cerebral blood flow and comorbid diagnosis in abstinent opioid addicts. Psychiatry Res. 1998, 83:117-126.
13. Hall W.D., Mattick R.P. Clinical update: codeine maintenance in opioid dependence. Lancet 2007, 370:550-552.
14. Harvey D.C., Lacan G., Tanious S.P., Melega W.P. Recovery from methamphetamine induced long-term nigrostriatal dopaminergic deficits without substantia nigra cell loss. Brain Res. 2000, 871:259-270.
15. Hutchings H.A., Eccles R. The opioid agonist codeine and antagonist naltrexone do not affect voluntary suppression of capsaicin induced cough in healthy subjects. Eur. Respir. J. 1994, 7:715-719.
16. Jia S.W., Wang W., Liu Y., Wu Z.M. Neuroimaging studies of brain corpus striatum changes among heroin-dependent patients treated with herbal medicine, U'finer capsule. Addict. Biol. 2005, 10:293-297.
17. Kish S.J., Kalasinsky K.S., Derkach P., Schmunk G.A., Guttman M., Ang L., Adams V., Furukawa Y., Haycock J.W. Striatal dopaminergic and serotonergic markers in human heroin users. Neuropsychopharmacology 2001, 24:561-567.
18. 99mTRODAT-1. Eur. J. Nucl. Med. 1996, 23:1527-1530.
19. Kung M.P., Stevenson D.A., Plossl K., Meegalla S.K., Beckwith A., Essman W.D., Mu M., Lucki I., Kung H.F. [99mTc]TRODAT-1: a novel technetium-99m complex as a dopamine transporter imaging agent. Eur. J. Nucl. Med. 1997, 24:372-380.
20. Lam C.M., Shek D. A qualitative study of cough medicine abuse among Chinese young people in Hong Kong. J. Subst. Abuse 2006, 11:233-244.
21. Lao Y.Z., Jiang Z.Y., Tong Z.S., Pang Z.T., Xu J.X. Clinical features and defense styles in patients with cough medicine abuse. Med. J. Chinese People's Health 2010, 22:272-274.
22. LaVoie M.J., Hastings T.G. Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine. J. Neurosci. 1999, 19:1484-1491.
23. Mattoo S.K., Basu D., Sharma A., Balaji M., Malhotra A. Abuse of codeine-containing cough syrups: a report from India. Addiction 1997, 92:1783-1787.
24. Melega W.P., Raleigh M.J., Stout D.B., Lacan G., Huang S.C., Phelps M.E. Recovery of striatal dopamine function after acute amphetamine- and methamphetamine-induced neurotoxicity in the vervet monkey. Brain Res. 1997, 766:113-120.
25. Robinson T.E., Kolb B. Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology 2004, 47(Suppl. 1):33-46.
26. Rose J.S., Branchey M., Buydens-Branchey L., Stapleton J.M., Chasten K., Werrell A., Maayan M.L. Cerebral perfusion in early and late opiate withdrawal: a technetium-99m-HMPAO SPECT study. Psychiatry Res. 1996, 67:39-47.
27. Shek D., Lam C.M. Beliefs about cough medicine abuse among Chinese young people in Hong Kong. Soc. Behav. Pers. 2008, 36:135-144.
28. Shek D.T., Lam C.M. Adolescent cough medicine abuse in Hong Kong: implications for the design of positive youth development programs in Hong Kong. Int. J. Adolesc. Med. Health 2006, 18:493-503.
29. Shi J., Zhao L.Y., Copersino M.L., Fang Y.X., Chen Y., Tian J., Deng Y., Shuai Y., Jin J., Lu L. PET imaging of dopamine transporter and drug craving during methadone maintenance treatment and after prolonged abstinence in heroin users. Eur. J. Pharmacol. 2008, 579:160-166.
30. Simantov R. Chronic morphine alters dopamine transporter density in the rat brain: possible role in the mechanism of drug addiction. Neurosci. Lett. 1993, 163:121-124.
31. Sklair-Tavron L., Shi W.X., Lane S.B., Harris H.W., Bunney B.S., Nestler E.J. Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:11202-11207.
32. Tjon G.H., De Vries T.J., Ronken E., Hogenboom F., Wardeh G., Mulder A.H., Schoffelmeer A.N. Repeated and chronic morphine administration causes differential long-lasting changes in dopaminergic neurotransmission in rat striatum without changing its delta- and kappa-opioid receptor regulation. Eur. J. Pharmacol. 1994, 252:205-212.
33. Volkow N.D., Chang L., Wang G.J., Fowler J.S., Franceschi D., Sedler M., Gatley S.J., Miller E., Hitzemann R., Ding Y.S., Logan J. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J. Neurosci. 2001, 21:9414-9418.
34. Volkow N.D., Fowler J.S., Wang G.J., Baler R., Telang F. Imaging dopamine's role in drug abuse and addiction. Neuropharmacology 2009, 56(Suppl. 1):3-8.
35. Volkow N.D., Fowler J.S., Wang G.J., Swanson J.M. Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol. Psychiatry 2004, 9:557-569.
36. Vree T.B., van Dongen R.T., Koopman-Kimenai P.M. Codeine analgesia is due to codeine-6-glucuronide, not morphine. Int. J. Clin. Pract. 2000, 54:395-398.
37. Yang Y., Yuan Q.Y. Investigation and analysis on personalities of male-codeine phosphate addicts by MMPI. Chinese J. Drug Abuse Prev. Treat. 2008, 14:143-145.